PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
1. Andreola S, Audisio RA, Mazzaferro V, Doci R, Milella M.
Spontaneous massive necrosis of a hepatocellular carcinoma.
Tumori 1987; 73(2): 203-207.
2. Todo S, Demetris AJ, Ueda Y, Imventarza O, Okuda K, Casavilla A, Cemaj S, Ghalab A,
Mazzaferro V, Rhoe BS, et al.
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and
steroids.
Transplantation Proceedings 1987; 19 (Suppl.6): 57-61.
3. Makowka L, Miller C, Chapchap P, Podesta L, Pan C, Pressley D, Mazzaferro V, Esquivel CO,
Todo S, Banner B, et al.
Prolongation of Pig-to-Dog renal xenograft survival by modification of the inflammatory mediator
rensponse.
Annals of Surgery 1987; 206: 482-495.
4. Todo S, Murase N, Kahn D, Pan CE, Okuda K, Cemej S, Casavilla A, Mazzaferro V, Ghalab A,
Rhoe BS, et al.
Effect of 15-deoxyspergualin on experimental organ transplantation.
Transplantation Proceedings 1988; 20 (Suppl.1): 233-236.
5. Ontell SJ, Makowka L, Mazzaferro V, Trager J, Ove P, Staral TE.
The protective effect of SRI 63-441 on ischemic liver injury using the isolated perfused Rat liver:
combined protocol with Superoxide Dismutase.
Transplantation Proceedings 1988; 20 (Suppl.1): 972-973.
6. Miller C, Mazzaferro V, Makowka L, Gordon RD, Todo S, Bowman J, Morris M, Ligush J, Starzl
TE.
Rapid flush technique for donor hepatectomy: safety and efficacy of an improved method of liver
recovery for transplantation.
Transplantation Proceedings 1988; 20 (Suppl.1): 948-950.
7. Azzarelli A, Quagliuolo V, Cerasoli S, Zucali R, Bignami P, Mazzaferro V, Dossena G, Gennari L.
Chordoma: natural history and treatment results in 33 cases.
Journal of Surgical Oncology 1988; 37(3): 185-191.
8. Miller C, Mazzaferro V, Makowka L, ChapChap P, Demetris J, Tzakis A, Esquivel CO, Iwatsuki
S, Starzl TE.
Orthotopic liver transplantation for massive hepatic lymphangiomatosis.
Surgery 1988; 103(4): 490-495.
9. Azzarelli A, Mazzaferro V, Quagliuolo V, Audisio RA, Colella G, Bandieramonte G, Dossena G,
Gennari L.
Kaposi's sarcoma: malignant tumor or proliferative disorder?
European Journal Cancer Clin. Oncol. 1988; 24(6): 973-978.
10. Tzakis AG, Mazzaferro V, Pan CE, Gordon RD, Todo S, Makowka L, Starzl TE.
Renal artery reconstruction for harvesting injuries in kidney transplantation with particular
reference to the use of vascular allografts.
Transplant International 1988; 1(2): 80-85.
1
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
11. Mazzaferro V, Dindzans VJ, Makowka L, Van Thiel DH.
Approach to hepatic metastases from colorectal adenocarcinoma.
Seminars in Liver Disease 1988; 8(3): 247-253.
12. Kahn D, Gavaler JS, Makowka L, Chapchap P, Mazzaferro V, Casavilla A, Smith MS, Eagon PK,
Starzl TE, Van Thiel DH.
Does hyperprolactinemia affect hepatic regeneration independent of sex steroids?
Journal of Laboratory and Clinical Medicine 1988; 112(5): 644-651.
13. Andreola S, Audisio RA, Mazzaferro V, Doci R, Makowka L, Gennari L.
Primary lymphoma of the liver showing immunohistochemical evidence of T-cell origin.
Successful management by right trisegmentectomy.
Digestive Diseases and Sciences 1988; 33(12): 1632-1636.
14. Marino I.R., Esquivel C.O., De Luca G., Santini E., Celli S., Napolitano M.M., Di Pietro C., Frena
A., Bevilacqua P., Cavicchioni C., Mazzaferro V., Markus B. H., De Francisci G., Falappa P.G.,
Perrelli L.
Orthotopic liver transplantation of liver grafts previously resected in situ.
Transplantation Proceedings 1988; 20 (Suppl.1): 548-551.
15. Marino I.R., De Luca G., Celli S., Santini E., Roncone A., Di Pietro C., Bevilacqua P., Frena A.,
Fresu R., Markus B.H., Mazzaferro V., Cavicchioni C.,. Sentinelli S, De Francisci G., Gualtieri E.,
Perrelli L.
Comparison of combined portal-arterial versus portal perfusion during liver procurement.
Transplantation Proceedings 1988; 20 (Suppl.1): 578-587.
16. Bronsther O., Makowka L., Jaffe R., Demetris A.J., Breining M.K., Ho M., Esquivel C.O., Gordon
R.D., Iwatsuki S., Tzakis A., Marsh jr J.W., Mazzaferro V., Van Thiel D., Starzl T.E.
Occurrence of Cytomegalovirus hepatitis in liver transplant patients.
Journal of Medical Virology 1988; 24(4): 423-434.
17. Mazzaferro V, Makowka L, Enrichens F, Kahn D, Ferla G, Banner B, Olivero G, Selby RR,
Stevenson WC, Todo S, et al.
A modified technique of orthotopic transplant of the kidney in rabbits.
J Invest Surg. 1989;2(3):293-303.
18. Kahn D, Mazzaferro V, Cervio G, Venkataramanan R, Makowka L, Van Thiel DH, Starzl TE.
Correlation between dose and level of cyclosporine after orthotopic liver transplantation.
Transplantation Proceedings 1989; 21(1): 2240-2241.
19. Mazzaferro V, Esquivel CO, Makowka L, Kahn D, Belle S, Kahn D, Scantlebury VP, Ferla G,
Koneru B, Scotti-Foglieni CL, et al.
Factors responsible for hepatic artery thrombosis after pediatric liver transplantation.
Transplantation Proceedings 1989; 21(1): 2466-2467.
20. Makowka L, Tzakis AG, Mazzaferro V, Teperman L, Demetris AJ, Iwatsuki S, Starzl TE.
Transplantation of the liver for metastatic endocrine tumors of the intestine and pancreas.
Surgery, Gynecology & Obstetrics 1989; 168(2): 107-111.
2
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
21. Ontell SJ, Makowka L, Trager J, Mazzaferro V, Ove P, Starzl TE.
Pharmacologic modulation of experimental postischemic hepatic function.
Annals of Surgery 1989; 209(2): 200-210.
22. Francavilla A, Polimeno L, DiLeo A, Barone M, Ove P, Coetzee M, Eagon P, Makowka L,
Ambrosino G, Mazzaferro V, et al.
The effect of estrogen and tamoxifen on hepatocyte proliferation in vivo and in vitro.
Hepatology 1989; 9(4): 614-620.
23. Mazzaferro V, Esquivel CO, Makowka L, Belle S, Kahn D, Koneru B, Scantlebury VP, Stieber
AC, Todo S, Tzakis AG, et al.
Hepatic artery thrombosis after pediatric liver transplantation--a medical or surgical event?
Transplantation 1989; 47(6): 971-977.
24. Francavilla A, Gavaler JS, Makowka L, Barone M, Mazzaferro V, Ambrosino G, Iwatsuki S,
Guglielmi FW, Dileo A, Balestrazzi A, et al.
Estradiol and testosterone levels in patients undergoing partial hepatectomy. A possible signal for
hepatic regeneration?
Digestive Diseases and Sciences 1989; 34(6): 818-822.
25. Markus BH, Dickson ER, Grambsch PM, Fleming TR, Mazzaferro V, Klintmalm GB, Wiesner
RH, Van Thiel DH, Starzl TE.
Efficacy of liver transplantation in patients with primary biliary cirrhosis.
New England Journal of Medicine 1989; 320(26): 1709-1713.
26. Belli L, Romani F, Belli LS, De Carlis L, Rondinara G, Baticci F, Del Favero E, Minola E, Donato
F, Mazzaferro V, et al.
Reappraisal of surgical treatment of
small hepatocellular carcinomas in cirrhosis:
clinicopathological study of resection or transplantation.
Digestive Diseases and Sciences 1989; 34(10): 1571-1575.
27. Scantlebury V, Gordon R, Tzakis A, Koneru B, Bowman J, Mazzaferro V, Stevenson WC, Todo S,
Iwatsuki S, Starzl TE.
Childbearing after liver transplantation.
Transplantation 1990; 49(2): 317-321.
28. Francavilla A, Barone M, Starzl TE, Zeevi A, Scotti C, Carrieri G, Mazzaferro V, Prelich J, Todo
S, Eiras G, et al.
FK 506 as a growth control factor.
Transplantation Proceedings 1990; 22(1): 90-92.
29. Mazzaferro V, Scotti-Foglieni CL, Porter KA, Trejo Bellido J, Carrieri G, Todo S, Fung JJ,
Francavilla A, Starzl TE.
Studies of the hepatotrophic qualities of FK 506 and CyA.
Transplantation Proceedings 1990; 22(1): 93-95.
30. Andreola S, Lombardi L, Audisio RA, Mazzaferro V, Koukouras D, Doci R,Gennari L, Makowka
L, Starzl TE, van Thiel DH.
A clinicopathologic study of primary hepatic carcinoid tumors.
Cancer 1990; 65(5): 1211-1218.
3
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
31. Mazzaferro V, Porter KA, Scotti-Foglieni CL, Venkataramanan R, Makowka L, Rossaro L,
Francavilla A, Todo S, Van Thiel DH, Starzl TE.
The hepatotropic influence of cyclosporine.
Surgery 1990; 107(5): 533-539.
32. Marino IR, Ferla G, Celli S, Stieber A, Muttillo I, Maggiano N, Mazzaferro V, Perrelli L, Musiani
P.
Hyperacute rejection of renal discordant xenograft (pig-to-rabbit): model assessment and rejection
mechanisms.
Transplantation Proceedings 1990; 22(3): 1071-1076.
33. Mazzaferro V, Todo S, Tzakis AG, Stieber AC, Makowka L, Starzl TE.
Liver transplantation in patients with previous portasystemic shunt.
American Journal of Surgery 1990; 160: 111-116.
34. Audisio RA, Doci R, Mazzaferro V, Bellegotti L, Tommasini M, Montalto F, Marchianò A, Piva
A, DeFazio C, Damascelli B, et al.
Hepatic arterial embolization with microencapsulated mitomycin C for unresectable hepatocellular
carcinoma in cirrhosis.
Cancer 1990; 66 : 228-236.
35. Andreola S, Cattoretti G, Lombardi L, Audisio RA, Regalia E, Bosch JP, Mazzaferro V, Doci R.
Inflammatory pseudotumor of the liver: report of two cases.
Tumori 1990; 76(5): 517-523.
36. Francavilla A, Panella C, Polimeno L, Giangaspero A, Mazzaferro V, Pan CE, Van Thiel DH,
Starzl TE.
Hormonal and enzymatic parameters of hepatic regeneration in patients undergoing major liver
resections.
Hepatology 1990; 12(5): 1134-1138.
37. Starzl TE, Porter KA, Mazzaferro V, Todo S, Fung J, Francavilla A.
Hepatotrophic effects of FK506 in dogs.
Transplantation 1991; 51: 67-71.
38. Alejandro R, Tzakis A, Ricordi C, Zeng Y, Todo S, Mazzaferro V, Mintz DH.
Combined liver-islet allotransplantation in man under FK 506.
Transplantation Proceedings 1991; 23(1): 789-92.
39. Stieber AO, Boillot O, Scotti-Foglieni C, Nalesnik MA, Gordon RD, Marino I, Mazzaferro V,
Starzl TE.
The surgical implications of the posttransplant lymphoproliferative disorders.
Transplantation Proceedings 1991; 23: 1477-1479.
40. Rossaro L, Mazzaferro V, Scotti-Foglieni CL, Williams DS, Simplaceanu E, Simplaceanu V,
Francavilla A, Starzl TE, Ho C, Van Thiel DH.
Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt
in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo.
Hepatology 1991; 13: 780-785.
4
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
41. Francavilla A, Barone M, Van Thiel DH, Mazzaferro V, Prelich JG, Starzl TE.
Further steps of hepatic stimulatory substance purification.
Digestive Diseases and Sciences 1991May;36(5):674-80
42. Rossaro L, Mazzaferro V, Scotti-Foglieni CL, Porter KA, Williams DS, Simplaceanu E,
Simplaceanu V, Francavilla A, Starzl TE, Ho C, et al.
Cyclosporine and liver regeneration studied by in vivo 31P nuclear magnetic resonance
spectroscopy.
Digestive Diseases and Sciences 1991; 36(5): 687-692.
43. Francavilla A, Panella C, Amoruso A, Giangaspero A, Gennari L, Mazzaferro V, Colella G, Van
Thiel DH, Starzl TE.
Role of estrogens and epidermal growth factor in hepatocellular carcinoma (HCC).
Digestive Diseases and Sciences 1991Sep;36(9):1299-302
44. Eagon PK, Francavilla A, DiLeo A, Elm MS, Gennari L, Mazzaferro V, Colella G, Van Thiel DH,
Strazl TE.
Quantitation of estrogen and androgen receptors in hepatocellular carcinoma and adjacent normal
human liver.
Digestive Disease and Science 1991; 36(9): 1303-8.
45. Kahn D, Cervio G, Mazzaferro V, Venkataramanan R, Makowka L, Van Thiel DH, Starzl TE.
Relationship between the dose and whole blood level of cyclosporine after liver and kidney
transplantation.
J Clin Lab Immunol. 1992;37(4):163-71.
46. Bozzetti F, Gennari L, Regalia E, Bignami P, Montalto F, Mazzaferro V, Doci R.
Morbidity and mortality after surgical resection of liver tumors. Analysis of 229 cases.
Hepatogastroenterology 1992; 39: 237-241.
47. Gennari L, Mazzaferro V, Regalia E, Colella G, Doci R, Bozzetti F, Ammatuna M, Andreola S,
Montalto F, Manzi R, et al.
Reappraisal of the role of liver transplantation in the treatment of hepatocellular carcinoma arising
in cirrhosis.
Journal Surgical Oncology 1993; 3: 83-86.
48. Gennari L, Doci R, Mazzaferro V, Colella G, Montalto F, Regalia E.
Hepatic resection for hepatocellular carcinoma
Journal Surgical Oncology 1993; 3: 62-66.
49. Mazzaferro V, Andreola S, Regalia E, Poli F, Doci R, Bozzetti F, Gennari L.
Confirmation of graft-versus-host disease after liver transplantation by PCR HLA-typing.
Transplantation 1993; 55: 423-425.
50. Colleoni M, Bajetta E, Nelli P, Boni L, Bochicchio AM, Nolè F, Buzzoni R, Celio L, Mazzaferro
V, Bonfanti G, et al.
Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic
chemotherapy: the experience of the National Cancer Institute of Milan.
Annals of Oncology 1993; 4: 489-493.
5
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
51. Mazzaferro V, Socci C, Regalia E, Andreola S, Di Bartolomeo M, Bertuzzi F, Di Carlo V, Pozza
G, Doci R, Bozzetti F, Gennari L.
Combined liver and pancreatic islets transplantation in man using cyclosporin immunosuppression.
Transplant International 1994; 7 (Suppl.1): 409-411.
52. Socci C, Mazzaferro V, Regalia E, Bertuzzi F, Andreola S, Colella G, Maffi P, Mirenda V,
Damascelli B, Magistretti P, et al.
Insulin independence after islet-liver transplantation for metastatic neuroendocrine pancreatic
tumor.
Transplantation Proceedings 1994; 26: 577-578.
53. Spreafico C, Marchianò A, Regalia E, Frigerio LF, Garbagnati F, Andreola S, Milella M, Lanocita
R, Mazzaferro V.
Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation.
Radiology 1994; 192: 687-690.
54. Mazzaferro V, Rondinara GF, Rossi G, Regalia E, De Carlis L, Caccamo L, Doci R, Sansalone CV,
Belli LS, Armiraglio E, et al.
Milan multicenter experience in liver transplantation for hepatocellular carcinoma.
Transplantation Proceedings 1994; 26: 3557-3560.
55. Sansalone CV, Colella G, Caccamo L, Rondinara GF, Fassati LR, Rossetti O, De Carlis L,
Galmarini D, Aseni P, Mazzaferro V, et al.
Orthotopic liver transplantation for primary biliary tumors: Milan multicenter experience.
Transplantation Proceedings 1994; 26: 3561-3563.
56. Regalia E, Sansalone C, Mazzaferro V, Reggiani P, Rondinara GF, Lucianetti A, Pulvirenti A, De
Carlis L, Paone G, Belli L, et al.
Pattern of recurrence of hepatocellular carcinoma after liver transplantation: Milan multicenter
experience.
Transplantation Proceedings 1994; 26: 4179-4180.
57. Belli LS, Caccamo L, Mazzaferro V, Silini E, Alberti A, Melada E, Regalia E, Gridelli B, Rubino
A, Gennari L, et al.
Milan multicenter experience in liver transplantation for hepatitis C-related cirrhosis: report of 105
cases.
Transplantation Proceedings 1994; 26: 3582-3584.
58. Caccamo L, Belli LS, Mazzaferro V, Colledan M, Alberti A, Regalia E, Fassati LR, Ideo G,
Rubino A, Belli L, et al.
Milan multicenter experience in 96 liver transplants for hepatitis B virus-related cirrhosis.
Transplantation Proceedings 1994; 26: 3585-3587.
59. Pulvirenti A, Regalia E, Bianchi E, Zuin M, Gennari L, Baratti D, Mazzaferro V.
Successful liver transplantation from a donor with chromosomal abnormality (45,XO).
Transplantation Proceedings 1994; 26: 4246-4247.
60. Scopsi L., Andreola S., Socci C., Bertuzzi F., Di Carlo V., Pozza G., Rilke F., Gennari L., Colella
G., Regalia E., Mazzaferro V.
Immunocytochemical detection and characterization of intrahepatic human pancreatic islets after
combined liver-islet allotransplantation.
6
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
Cell Transplantation 1994; 3(6): 499-508.
61. Cozzi G, Colella G, Bellomi M, Colnago MF, Salvetti M, Regalia E, Mazzaferro V, Severini A.
Use of safety catheter after removal of Kehr's tube in liver transplant patients].
Radiol Med. 1995 Jan-Feb;89(1-2):91-3.
62. Di Bartolomeo M, Bajetta E, Bochicchio AM, Carnaghi C, Somma L, Mazzaferro V, Visini M,
Gebbia V, Tumolo S, Ballatore P.
A phase II trial of dacarbazine, fluorouracil and epirubicin in patients with neuroendocrine
tumours. A study by the Italian Trials in Medical Oncology (I.T.M.O.) Group.
Annals of Oncology 1995; 6: 77-79.
63. Bajetta E, Carnaghi C, Ferrari L, Spagnoli I, Mazzaferro V, Buzzoni R.
The role of somatostatin analogues in the treatment of gastro-enteropancreatic endocrine tumours.
Digestion 1996; 57: 72-76.
64. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M,
Morabito A, Gennari L.
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with
cirrhosis.
New England Journal of Medicine 1996; 334: 693-699.
65. Mazzaferro V, Regalia E, Montalto F, Pulvirenti A, Brunetto MR, Bonino F, Lerut J, Gennari L.
Risk of HBV reinfection after liver transplantation in HBsAg-positive cirrhosis. Primary
hepatocellular carcinoma is not a predictor for HBV recurrence. The European Cooperative Study
Group on Liver Cancer and Transplantation.
Liver 1996; 16:117-122.
66. Granata C, Haupt R, Mazzaferro V, Fratino G, Mattioli G, Gasparini M, De Bernardi B.
Carcinoid syndrome.
Pediatric Surgery International 1996; 11: 398-399.
67. Luzi L, Hering BJ, Socci C, Raptis G, Battezzati A, Terruzzi I, Falqui L, Brandhorst H, Brandhorst
D, Regalia E, Brambilla E, Secchi A, Perseghin G, Maffi P, Bianchi E, Mazzaferro V, Gennari L,
Di Carlo V, Federlin K, Pozza G, Bretzel RG.
Metabolic effects of successful intraportal islet transplantation ininsulin-dependent diabetes
mellitus.
Journal of Clinical Investigation 1996; 97: 2611-2618.
68. Filiberti A, Mencaglia E, Regalia E, Gangeri L, Pulvirenti A, Tamburini M, Camisasca M,
Quagliuolo M, Mazzaferro V.
Psychosocial adaptation after liver transplantation with particular reference to recipients aware of
their cancer.
European Journal of Surgical Oncology 1996; 22: 240-244.
69. Mazzaferro V, Regalia E, Pulvirenti A, Baratti D, Montagnino G, Bozzetti F.
Renal-splenic shunt for infrahepatic caval occlusion after piggy-back liver transplantation.
Transplant International 1997; 10:392-394.
70. Mazzaferro V, Regalia E, Pulvirenti A, Tagger A, Andreola S, Pasquali M, Baratti D, Romano F,
Palazzo U, Zuin M, Bonino F, Ribero ML, Gennari L.
7
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin
combination.
Transplantation Proceedings 1997; 29: 519-521.
71. Luzi L, Perseghin G, Regalia E, Sereni LP, Battezzati A, Baratti D, Bianchi E, Terruzzi I, Hilden
H, Groop LC, Pulvirenti A, Taskinen MR, Gennari L, Mazzaferro V.
Metabolic effects of liver transplantation in cirrhotic patients.
Journal of Clinical Investigation 1997; 99: 692-700.
72. Spreafico C, Marchianò A, Mazzaferro V, Frigerio LF, Regalia E, Lanocita R, Patelli G, Andreola
S, Garbagnati F, Damascelli B.
Hepatocellular carcinoma in patients who undergo liver transplantation: sensitivity of CT with
iodized oil.
Radiology 1997; 203: 457-460.
73. Mazzaferro V, Brunetto MR, Pasquali M, Regalia E, Pulvirenti A, Baratti D, Makowka L, Van
Thiel D, Bonino F.
Preoperative serum levels of wild-type and hepatitis B e antigen-negative hepatitis B virus (HBV)
and graft infection after liver transplantation for HBV-related hepatocellular carcinoma.
Journal of Viral Hepatitis 1997; 4:235-242.
74. Perseghin G, Regalia E, Battezzati A, Vergani S, Pulvirenti A, Terruzzi I, Baratti D, Bozzetti F,
Mazzaferro V, Luzi L.
Regulation of glucose homeostasis in humans with denervated livers.
Journal of Clinical Investigation 1997; 100: 931-941.
75. Severini A, Cozzi G, Salvetti M, Mazzaferro V, Doci R.
Management of complications from hepatobiliary surgery using the percutaneous transjejunal
approach.
Tumori 1997; 83, 6: 912-917.
76. Savelli G, Chiti A, Spinelli A, Regalia E, Mazzaferro V, Castellani MR, Balzarini L, Musumeci R,
Bombardieri E.
Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin
receptor scintigraphy.
Tumori 1998; 84: 82-84.
77. Regalia E, Fassati LR, Valente U, Pulvirenti A, Damilano I, Dardano G, Montalto F, Coppa J,
Mazzaferro V.
Pattern and management of recurrent hepatocellular carcinoma after liver transplantation.
Journal of Hepatobiliary Pancreatic Surgery 1998; 5: 29-34.
78. Mastroianni A, Regalia E, Facchetti G, Longoni PD, Formelli F, Pulvirenti A, Mazzaferro V.
Increased retinol binding protein in the sera of patients with severe ischemic damage of the liver
after transplantation.
Clinical Biochemistry 1998; 31: 113-116.
79. Perseghin G, Baratti D, Benedini S, Regalia E, Mazzaferro V, Luzi L.
Effect of liver transplantation in cirrhotic diabetic patients.
Transplantation Proceedings 1998; 30(5): 1868
8
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
80. Battezzati A, Bonfatti D, Benedini S, Calori G, Caldara R, Mazzaferro V, Elli A, Secchi A, Di
Carlo V, Pozza G, Luzi L.
Spontaneous hypoglycaemia after pancreas transplantation in Type 1 diabetes mellitus.
Diabetic Medicine 1998; 15: 991-996.
81. Misiakos EP, Pinna A, Kato T, Rodriguez MG, Francavilla A, Mazzaferro V, Ruiz P, Reith JD,
Tzakis AG.
Recurrence of desmoid tumor in a multivisceral transplant patient with Gardner's syndrome.
Transplantation 1999; 67(8): 1197-1199.
82. Bajetta E, Di Bartolomeo M, Stani SC, Artale S, Ricci SB, Bozzetti F, Mazzaferro V, Toffolatti L,
Buzzoni R.
Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer
patients: results of a feasibility study.
International Journal Radiation Oncology Biol. Phys. 1999; 45 (2): 285-289.
83. Pineau P, Meddeb M, Raselli R, Qin LX, Terris B, Tang ZY, Tiollais P, Mazzaferro V, Dejean A.
Effect of TT virus infection on hepatocellular carcinoma development: results of a Euro-Asian
survey.
Journal of Infectious Diseases 2000; 181 (3): 1138-42.
84. Perseghin G, Mazzaferro V, Sereni LP, Regalia E, Benedini S, Bazzigaluppi E, Pulvirenti A, Leão
AA, Calori G, Romito R, Baratti D, Luzi L.
Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous
diabetes: effect of liver transplantation.
Hepatology 2000; 31 (3): 694-703.
85. Ferlini A, Obici L, Manzati E, Biadi O, Tarantino E, Conigli P, Merlini G, D'Alessandro M,
Mazzaferro V, Tassinari CA, Salvi F.
Mutation and transcription analysis of transthyretin gene in Italian families with hereditary
amyloidosis: a putative novel hot spot' in codon 47.
Clinical Genetic 2000; 57: 284-290.
86. Rossi S, Garbagnati F, Lencioni R, Allgaier HP, Marchianò A, Fornari F, Quaretti P, Tolla GD,
Ambrosi C, Mazzaferro V, Blum HE, Bartolozzi C.
Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after
occlusion of tumor blood supply
Radiology 2000; 217 (1): 119-126.
87. Adam R., Cailliez V. , Majno P. et Al. with Contributing Centers (Istituto Nazionale Tumori,
Mazzaferro V.).
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry
study.
Lancet 2000; 356: 621-627.
88. Burra P., Smedile A., Ascione M., Rizzetto M.
Mazzaferro V.)
Liver transplantation in Italy: current status
Digestive and Liver Diseases 2000; 32: 249-256.
and A.I.S.F. (Istituto Nazionale Tumori:
9
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
89. Mazzaferro V, Tagger A, Schiavo M, Regalia E, Pulvirenti A, Ribero ML, Coppa J, Romito R,
Burgoa L, Zucchini N, Urbanek T, Bonino F.
Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin
treatment.
Transplantation Proceedings 2001; 33 (1-2): 1355-1357.
90. Regalia E, Coppa J, Pulvirenti A, Romito R, Schiavo M, Burgoa L, Mazzaferro V.
Liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience.
Transplantation Proceedings 2001; 33 (1-2): 1442-1444.
91. Pulvirenti A, Garbagnati F, Regalia E, Coppa J, Marchiano A, Romito R, Schiavo M, Fabbri A,
Burgoa L, Mazzaferro V.
Experience with radiofrequency ablation of small hepatocellular carcinomas before liver
transplantation.
Transplantation Proceedings 2001; 33 (1-2): 1516-1517.
92. Coppa J, Pulvirenti A, Schiavo M, Romito R, Collini P, Di Bartolomeo M, Fabbri A, Regalia E,
Mazzaferro V.
Resection versus transplantation for liver metastases from neuroendocrine tumors.
Transplantation Proceedings 2001; 33 (1-2): 1537-1539.
93. Perseghin G., Caloni M., Mazzaferro V., Luzi L.
Hepatogenic diabetes.
Recenti Prog Med. 2001 Dec;92(12):757-61.
94. Gangeri L, Tamburini M, Borreani C, Brunelli C, Miccinesi G, Murru L, Boeri P, Mazzaferro V.
Candidates for liver transplantation for cancer: physical, psychological, and social conditions.
Transplantation 2002; 73 (10): 1627-1635.
95. Battezzati A, Caumo A, Fattorini A, Sereni LP, Coppa J, Romito R, Ammatuna M, Regalia E,
Mazzaferro V, Luzi L.
Amino acid kinetics during the anhepatic phase of liver transplantation.
Diabetes 2002, 51 (6); 1690-1698.
96. Deraco M, Gronchi A, Mazzaferro V, Inglese MG, Pennacchioli E, Kusamura S, Rizzi M, Anselmi
RA Jr, Vaglini M.
Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with
Pseudomyxoma peritonei.
Tumori 2002; 88(5): 370-375.
97. Perseghin G, Mazzaferro V, Benedini S, Pulvirenti A, Coppa J, Regalia E, Luzi L.
Resting energy expenditure in diabetic and nondiabetic patients with liver cirrhosis: relation with
insulin sensitivity and effect of liver transplantation and immunosuppressive therapy.
American Journal of Clinical Nutrition 2002; 76: 541-548.
98. Luzi L, Regalia E, Pulvirenti A, Piceni Sereni L, Spessot M, Romito R, Baratti D, Terruzzi I,
Mazzaferro V.
Post-absorptive and insulin-mediated muscle protein metabolism in liver-transplanted patients.
Acta Diabetologica 2002; 39(4): 203-208.
10
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
99. Fagiuoli S., Mirante V.G., Pompili M., Gianni S., Leandro G., Rapaccini G.L., Gasbarrini A.,
Naccarato R, Pagliaro L., Rizzetto M., Gasbarrini G. and the Monotematica AISF 2000 OLT
Study Group (Mazzaferro V.)
Liver Transplantation: the Italian experience.
Digestive and Liver Disease 2002; 34: 640-648
100. Casanova M, Collini P, Ferrari A, Cecchetto G, Dall'Igna P, Mazzaferro V.
Solid-pseudopapillary tumor of the pancreas (Frantz tumor) in children.
Medical and Pediatric Oncology 2003; 41(1): 74-76.
101. Mazzaferro V, Coppa J, Carrabba MG, Rivoltini L, Schiavo M, Regalia E, Mariani L, Camerini T,
Marchianò A, Andreola S, Camerini R, Corsi M, Lewis JJ, Srivastava PK, Parmiani G.
Vaccination with autologous tumor-derived heat-shock protein gp96 after liver resection for
metastatic colorectal cancer.
Clinical Cancer Research 2003, 15 (9): 3235-3245.
102. Perseghin G, Caumo A, Mazzaferro V, Pulvirenti A, Piceni Sereni L, Romito R, Lattuada G,
Coppa J, Costantino F, Regalia E, Luzi L.
Assessment of insulin sensitivity based on a fasting blood sample in men with liver cirrhosis before
and after liver transplantation.
Transplantation 2003; 76(4): 697-702.
103. Martel M, Sarli D, Colecchia M, Coppa J, Romito R, Schiavo M, Mazzaferro V, Rosai J.
Fibroblastic reticular cell tumor of the spleen: report of a case and review of the entity.
Human Pathology 2003; 34(9): 954-97.
104. Rivoltini L, Castelli C, Carrabba M, Mazzaferro V, Pilla L, Huber V, Coppa J, Gallino G,
Scheibenbogen C, Squarcina P, Cova A, Camerini R, Lewis JJ, Srivastava PK, Parmiani G.
Human tumor-derived heat shock protein 96 mediates in vitro activation and in vivo expansion of
melanoma- and colon carcinoma-specific T cells.
Journal of Immunology 2003; 171(7): 3467-74.
105. J, Salizzoni M, Pollard S, Muhlbacher F, Rogiers X, Garcia Valdecasas JC, Berenguer J, Jaeck D,
Moreno Gonzalez E; European Liver Transplant Association (Istituto Nazionale Tumori, Milano:
V.Mazzaferro).
Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry
Liver Transplantation 2003; 9(12): 1231-43.
106. Battezzati A, Caumo A, Martino F, Sereni LP, Coppa J, Romito R, Ammatuna M, Regalia E,
Matthews DE, Mazzaferro V, Luzi L.
Nonhepatic glucose production in humans.
American J. Physiol. Endocrinol. Metab. 2004; 268: E: 129-135.
107. Pellicano R, Mazzaferro V, Grigioni WF, Cutufia MA, Fagoonee S, Silengo L, Rizzetto M,
Ponzetto A.
Helicobacter species sequences in liver samples from patients with and without hepatocellular
carcinoma.
World Journal of Gastroenterology 2004; 10(4): 598-601.
108. Castelli C, Rivoltini L, Rini F, Belli F, Testori A, Maio M, Mazzaferro V, Coppa J, Srivastava PK,
Parmiani G.
11
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
Heat shock proteins: biological functions and clinical application as personalized vaccines for
human cancer.
Cancer Immunology Immunotherapy 2004; 53(3): 227-33.
109. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, Sarli D, Schiavo M,
Garbagnati F, Marchianò A, Spreafico C, Camerini T, Mariani L, Miceli R, Andreola S.
Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver
transplantation: a prospective study.
Annals of Surgery 2004; 240(5):900-909.
110. Parmiani G, Testori A, Maio M, Castelli C, Rivoltini L, Pilla L, Belli F, Mazzaferro V, Coppa J,
Patuzzo R, Sertoli MR, Hoos A, Srivastava PK, Santinami M.
Heat shock proteins and their use as anticancer vaccines.
Clinical Cancer Research 2004; 10: 8142-8146.
111. Llovet JM, Schwartz M, Mazzaferro V.
Resection and liver transplantation for hepatocellular carcinoma.
Seminars in Liver Disease 2005; 25(2): 181-198.
112. Casanova M, Massimino M, Ferrari A, Spreafico F, Piva L, Coppa J, Luksch R, Cefalo G,
Terenziani M, Polastri D, Bellani FF, Mazzaferro V.
Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
Pediatric Hematology and Oncology 2005; 22(3): 189-198.
113. Marzano A, Lampertico P, Mazzaferro V, Carenzi S, Vigano M, Romito R, Pulvirenti A,
Franchello A, Colombo M, Salizzoni M, Rizzetto M.
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudineresistant mutants.
Liver Transplantation 2005; 11(5):532-538.
114. Pilla L, Squarcina P, Coppa J, Mazzaferro V, Huber V, Pende D, Maccalli C, Sovena G, Mariani L,
Castelli C, Parmiani G, Rivoltini L.
Natural killer and NK-Like T-cell activation in colorectal carcinoma patients treated with
autologous tumor-derived heat shock protein 96.
Cancer Research 2005; 65 (9): 3942-3949.
115. Majno P, Mentha G, Mazzaferro V.
Resection, transplantation, either, or both? Other pieces of the puzzle.
Liver Transplantation 2005; 11(10):1177-1180.
116. Cardillo M, De Fazio N, Pedotti P, De Feo T, Fassati LR, Mazzaferro V, Colledan M, Gridelli B,
Caccamo L, DeCarlis L, Valente U, Andorno E, Cossolini M, Martini C, Antonucci A, Cillo U,
Zanus G, Baccarani U, Scalamogna M; NITp Liver Transplantation Working Group.
Split and whole liver transplantation outcomes: a comparative cohort study.
Liver Transplantation 2006; 12(3): 402-10.
117. Rimessi P, Spitali P, Ando Y, Mazzaferro V, Pastorelli F, Tassinari CA, Calzolari E, Salvi F,
Ferlini A
Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic
polyneuropathy, and identification of a dual transcription start point.
Liver International 2006; 26: 211-220.
12
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
118. Cozzi G, Severini A, Civelli E, Milella M, Pulvirenti A, Salvetti M, Romito R, Suman L,
Chiaraviglio F, Mazzaferro V.
Percutaneous transhepatic biliary drainage in the management of postsurgical biliary leaks in
patients with nondilated intrahepatic bile ducts.
CardioVascular Interventional Radiology 2006; 29(3): 380-8.
119. Majno P, Mazzaferro V.
Living donor liver transplantation for hepatocellular carcinoma exceeding conventional criteria:
questions, answers and demands for a common language.
Liver Transplantation 2006; 12(6):896-898.
120. Mazzaferro V, Romito R, Schiavo M, Mariani L, Camerini T, Bhoori S, Capussotti L, Calise F,
Pellicci R, Belli G, Tagger A, Colombo M, Bonino F, Majno P, Llovet JM; HCC Italian Task
Force.
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in
HCV cirrhosis.
Hepatology 2006; 44: 1543-1554.
121. Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang
W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL.
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in
HCV cirrhosis.
Gastroenterology 2006; 131:1758-1767.
122. Burroughs AK1, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, O'Grady JG, Castaing D,
Klempnauer J, Jamieson N, Neuhaus P, Lerut J, de Ville de Goyet J, Pollard S, Salizzoni M,
Rogiers X, Muhlbacher F, Garcia Valdecasas JC, Broelsch C, Jaeck D, Berenguer J, Gonzalez EM,
Adam R; European Liver Transplant Association (Istituto Nazionale Tumori, Milano:
V.Mazzaferro).
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models
for outcome
Lancet 2006; 367: 225–232.
123. Kremer-Tal S, Narla G, Chen Y, Hod E, DiFeo A, Yea S, Lee JS, Schwartz M, Thung SN, Fiel IM,
Banck M, Zimran E, Thorgeirsson SS, Mazzaferro V, Bruix J, Martignetti JA, Llovet JM,
Friedman SL.
Downregulation of KLF6 is an early event in hepatocarcinogenesis, and stimulates proliferation
while reducing differentiation..
Journal of Hepatology 2007; 46: 645-654.
124. Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S,
Mazzaferro V, Bruix J, Bottinger E, Friedman S, Waxman S, Llovet JM.
Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.
Hepatology 2007; 45: 938-947.
125. Gangeri L, Bosisio M, Brunelli C, Tamburini M, Serafin P, Clerici CA, Caraceni A, Mazzaferro V.
Phenomenology and emotional impact of neuropsychiatric symptoms in orthotopic liver transplant
for hepatocellular carcinoma.
Transplantation Proceedings 2007; 39:1564-1568.
13
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
126. Bhoori S, Schiavo M, Russo A, Mazzaferro V.
First-line treatment for hepatocellular carcinoma: resection or transplantation?
Transplantation Proceedings 2007; 39: 2271-2273.
127. Mazzaferro V, Pulvirenti A, Coppa J.
Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation?
Journal of Hepatology 2007; 47:460-466.
128. Mazzaferro V.
Results of liver transplantation: with or without Milan criteria?
Liver Transplantation 2007, 13 (11 Suppl 2): S44-7.
129. Lerut JP, Orlando G, Adam R, Schiavo M, Klempnauer J, Mirza D, Boleslawski E, Burroughs A,
Sellés CF, Jaeck D, Pfitzmann R, Salizzoni M, Söderdahl G, Steininger R, Wettergren A,
Mazzaferro V, Le Treut YP, Karam V; European Liver Transplant Registry.
The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma:
report of the European liver transplant registry.
Annals of Surgery 2007, 246: 949-957.
130. Mattavelli F, Collini P, Pizzi N, Gervasoni C, Pennacchioli E, Mazzaferro V;
Thyroid Cancer Study Group of INT Milan.
Thyroid as a target of metastases. A case of foregut neuroendocrine carcinoma with multiple
abdominal metastases and a thyroid localization after 21 years.
Tumori 2008; 94: 110-113.
131. Mazzaferro V, Chun YS, Poon RT, Schwartz ME, Yao FY, Marsh JW, Bhoori S, Lee SG.
Liver transplantation for hepatocellular carcinoma.
Annals of Surgical Oncology 2008; 15: 1001–1007.
132. Pineau P, Marchio A, Battiston C, Cordina E, Russo A, Terris B, Qin LX, Turlin B, Tang ZY,
Mazzaferro V, Dejean A.
Chromosome instability in human hepatocellular carcinoma depends on p53 status and aflatoxin
exposure.
Mutation Research 2008; 653: 6-13.
133. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul
JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath
I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators
Study Group.
Sorafenib in advanced hepatocellular carcinoma.
New England Journal of Medicine 2008; 359: 378-390.
134. Chiang DY, Villanueva A, Hoshida Y, Peix J, Newell P, Minguez B, LeBlanc AC, Donovan DJ,
Thung SN, Solé M, Tovar V, Alsinet C, Ramos AH, Barretina J, Roayaie S, Schwartz M, Waxman
S, Bruix J, Mazzaferro V, Ligon AH, Najfeld V, Friedman SL, Sellers WR, Meyerson M, Llovet
JM.
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma.
Cancer Research 2008, 68: 6779-6788.
135. Hoshida Y, Villanueva A, Kobayashi M, Peix J, Chiang DY, Camargo A, Gupta S, Moore J,
Wrobel MJ, Lerner J, Reich M, Chan JA, Glickman JN, Ikeda K, Hashimoto M, Watanabe G,
14
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
Daidone MG, Roayaie S, Schwartz M, Thung S, Salvesen HB, Gabriel S, Mazzaferro V, Bruix J,
Friedman SL, Kumada H, Llovet JM, Golub TR.
Gene expression in fixed tissues and outcome in hepatocellular carcinoma.
New England Journal of Medicine 2008; 359:1995-2004.
136. Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B,
Sole M, Battiston C, Van Laarhoven S, Fiel MI, Di Feo A, Hoshida Y, Yea S, Toffanin S, Ramos
A, Martignetti JA, Mazzaferro V, Bruix J, Waxman S, Schwartz M, Meyerson M, Friedman SL,
Llovet JM.
Pivotal role of mTOR signaling in hepatocellular carcinoma.
Gastroenterology 2008; 135: 1972-1983.
137. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S,
Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo
U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J,
Rochling F, Van Hoek B, Majno P; Metroticket Investigator Study Group.
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the
Milan criteria: a retrospective, exploratory analysis.
Lancet Oncology 2009; 10:35-43.
138. Newell P, Toffanin S, Villanueva A, Chiang DY, Minguez B, Cabellos L, Savic R, Hoshida Y,
Lim KH, Melgar-Lesmes P, Yea S, Peix J, Deniz K, Fiel MI, Thung S, Alsinet C, Tovar V,
Mazzaferro V, Bruix J, Roayaie S, Schwartz M, Friedman SL, Llovet JM.
Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib
and rapamycin in vivo.
Journal of Hepatology 2009; 51(4): 725-33.
139. Morosi C, Civelli E, Battiston C, Schiavo M, Mazzaferro V, Severini A, Marchianò A.
CT cholangiography: assessment of feasibility and diagnostic reliability.
European Journal of Radiology 2009; 72:114–117
140. Porretti L, Cattaneo A, Colombo F, Lopa R, Rossi G, Mazzaferro V, Battiston C, Svegliati-Baroni
G, Bertolini F, Rebulla P, Prati D.
Simultaneous characterization of progenitor cell compartments in adult human liver.
Cytometry Part A 2010; 77(1):31-40.
141. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW,
Croce CM, Dejean A.
miR-221 overexpression contributes to liver tumorigenesis.
Proceedings of the National Academy of Sciences U S A. 2010; 107(1): 264-9.
142. Tovar V, Alsinet C, Villanueva A, Hoshida Y, Chiang DY, Solé M, Thung S, Moyano S, Toffanin
S, Mínguez B, Cabellos L, Peix J, Schwartz M, Mazzaferro V, Bruix J, Llovet JM.
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of
IGF-1R blockage.
Journal of Hepatology 2010, 52(4):550-9.
143. Majno PE, Mentha G, Mazzaferro V.
Partial hepatectomy versus radiofrequency ablation for hepatocellular carcinoma: confirming the
trial that will never be, and some comments on the indications for liver resection.
Hepatology 2010; 51(4):1116-8.
15
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
144. Bhoori S, Toffanin S, Sposito C, Germini A, Pellegrinelli A, Lampis A, Mazzaferro V.
Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver
transplantation: a proof of principle.
Journal of Hepatology 2010; 52: 771-775
145. Cozzaglio L, Coladonato M, Biffi R, Coniglio A, Corso V, Dionigi P, Gianotti L, Mazzaferro V,
Morgagni P, Rosa F, Rosati R, Roviello F, Doci R.
Duodenal fistula after elective gastrectomy for malignant disease : an Italian retrospective
multicenter study.
Journal of Gastrointestinal Surgery 2010, 14(5):805-11
146. Schnitzbauer AA, Zuelke C, Graeb C, Rochon J, Bilbao I, Burra P, de Jong KP, Duvoux C,
Kneteman NM, Adam R, Bechstein WO, Becker T, Beckebaum S, Chazouillères O, Cillo U,
Colledan M, Fändrich F, Gugenheim J, Hauss JP, Heise M, Hidalgo E, Jamieson N, Königsrainer
A, Lamby PE, Lerut JP, Mäkisalo H, Margreiter R, Mazzaferro V, Mutzbauer I, Otto G, Pageaux
GP, Pinna AD, Pirenne J, Rizell M, Rossi G, Rostaing L, Roy A, Turrion VS, Schmidt J, Troisi RI,
van Hoek B, Valente U, Wolf P, Wolters H, Mirza DF, Scholz T, Steininger R, Soderdahl G,
Strasser SI, Jauch KW, Neuhaus P, Schlitt HJ, Geissler EK.
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTORinhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular
carcinoma.
BMC Cancer 2010; 10(1):190.
147. Vartanian JP, Henry M, Marchio A, Suspène R, Aynaud MM, Guétard D, Cervantes-Gonzalez M,
Battiston C, Mazzaferro V, Pineau P, Dejean A, Wain-Hobson S.
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis.
PLoS Pathogens 2010; 6(5): e1000928.
148. Bhoori S, Sposito C, Germini A, Coppa J, Mazzaferro V.
The challenges of liver transplantation for hepatocellular carcinoma on cirrhosis.
Transplant International 2010;23(7): 712-2.2
149. de Herder WW, Mazzaferro V, Tavecchio L, Wiedenmann B.
Multidisciplinary approach for the treatment of neuroendocrine tumors.
Tumori 2010; 96: 833-46.
150. Rivoltini L, Mazzaferro V.
Exploiting liver immunity for the prevention of hepatic metastases.
Journal of Hepatology 2010;53(4):596-8.
151. Colombo F, Baldan F, Mazzucchelli S, Martin-Padura I, Marighetti P, Cattaneo A, Foglieni B,
Spreafico M, Guerneri S, Baccarin M, Bertolini F, Rossi G, Mazzaferro V, Cadamuro M,
Maggioni M, Agnelli L, Rebulla P, Prati D, Porretti L.
Evidence of distinct tumour-propagating cell populations with different properties in primary
human hepatocellular carcinoma.
PLoS One 2011;6(6):e21369. Epub 2011 Jun 23.
152. Angelico M, Cillo U, Fagiuoli S, Gasbarrini A, Gavrila C, Marianelli T, Costa AN, Nardi A,
Strazzabosco M, Burra P, Agnes S, Baccarani U, Calise F, Colledan M, Cuomo O, De Carlis L,
16
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
Donataccio M, Ettorre GM, Gerunda GE, Gridelli B, Lupo L, Mazzaferro V, Pinna A, Risaliti A,
Salizzoni M, Tisone G, Valente U, Rossi G, Rossi M, Zamboni F; Liver Match Investigators.
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design
and current practice of donor-recipient matching.
Digestive and Liver Disease 2011; 43:155-64.
153. Chiesa C, Maccauro M, Romito R, Spreafico C, Pellizzari S, Negri A, Sposito C, Morosi C, Civelli
E, Lanocita R, Camerini T, Bampo C, Bhoori S, Seregni E, Marchianò A, Mazzaferro V,
Bombardieri E.
Need, feasibility and convenience of dosimetric treatment planning in liver selective internal
radiation therapy with (90)Y microspheres: the experience of the National Tumor Institute of
Milan.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2011, 55:168-97.
154. Mazzaferro V, Majno P.
Principles for the best multidisciplinary meetings.
Lancet Oncolgy 2011;12(4):323-5.
155. Villanueva A, Hoshida Y, Battiston C, Tovar V, Sia D, Alsinet C, Cornella H, Liberzon A,
Kobayashi M, Kumada H, Thung SN, Bruix J, Newell P, April C, Fan JB, Roayaie S, Mazzaferro
V, Schwartz ME, Llovet JM.
Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular
carcinoma.
Gastroenterology 2011;140(5):1501-12.
156. Toffanin S, Hoshida Y, Lachenmayer A, Villanueva A, Cabellos L, Minguez B, Savic R, Ward SC,
Thung S, Chiang DY, Alsinet C, Tovar V, Roayaie S, Schwartz M, Bruix J, Waxman S, Friedman
SL, Golub T, Mazzaferro V, Llovet JM.
MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a.
Gastroenterology 2011;140(5):1618-28.
157. Raoul JL, Sangro B, Forner A, Mazzaferro V, Piscaglia F, Bolondi L, Lencioni R.
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available
evidence and expert opinion on the use of transarterial chemoembolization.
Cancer Treatment Reviews 2011;37: 212-220.
158. Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, Mariani L.
Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of
15 years of experience.
Liver Transpl. 2011 Oct;17 Suppl 2:S44-57
159. Prasad KR, Young RS, Burra P, Zheng SS, Mazzaferro V, Moon DB, Freeman RB.
Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular
carcinoma: a review and consensus statement.
Liver Transplantation 2011;17 Suppl 2:S81-9.
160. Mínguez B, Hoshida Y, Villanueva A, Toffanin S, Cabellos L, Thung S, Mandeli J, Sia D, April
C, Fan JB, Lachenmayer A, Savic R, Roayaie S, Mazzaferro V, Bruix J, Schwartz M, Friedman
SL, Llovet JM.
Gene-expression signature of vascular invasion in hepatocellular carcinoma.
Journal of Hepatology 2011;55(6):1325-31.
17
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
161. Gavazzi C, Colatruglio S, Sironi A, Mazzaferro V, Miceli R.
Importance of early nutritional screening in patients with gastric cancer.
Br J Nutr. 2011 Dec;106(12):1773-8.
162. Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, Tisone
G, Romagnoli R, Caccamo L, Rossi M, Vitale A, Cucchetti A, Lupo L, Gruttadauria S, Nicolotti
N, Burra P, Gasbarrini A, Agnes S; Donor-to-Recipient Italian Liver Transplant (D2R-ILTx) Study
Group.
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with
particular reference to HCV recipients.
Am J Transplant. 2011;11(12):2724-36.
163. Maggi U, Andorno E, Rossi G, De Carlis L, Cillo U, Bresadola F, Mazzaferro V, Risaliti A,
Bertoli P, Consonni D, Barretta F, De Feo T, Scalamogna M.
Liver retransplantation in adults: the largest multicenter Italian study.
PLoS One. 2012;7(10):e46643.
164. Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A; OLT for HCC Consensus
Group.
Recommendations for liver transplantation for hepatocellular carcinoma: an international
consensus conference report.
Lancet Oncology 2012 Jan;13(1):e11-22.
165. European Association for Study of Liver; European Organisation for Research and Treatment of
Cancer.
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.
Eur J Cancer 2012; 48(5):599-641
166. European Association For The Study Of The Liver; European Organisation For Research And
Treatment Of Cancer.
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.
Journal of Hepatology 2012; 56(4):908-43
167. Gish RG, Lencioni R, Di Bisceglie AM, Raoul JL, Mazzaferro V.
Role of the multidisciplinary team in the diagnosis and treatment of hepatocellular carcinoma.
Expert Rev Gastroenterol Hepatol. 2012;6(2): 173-85. Review.
168. Llovet JM, Peña CE, Lathia CD, Shan M, Meinhardt G, Bruix J; SHARP Investigators Study
Group.
Plasma biomarkers as predictors of outcome in patients with advanced hepatocellular carcinoma.
Clinical Cancer Research 2012;18(8):2290-300.
169. Raoul JL, Bruix J, Greten TF, Sherman M, Mazzaferro V, Hilgard P, Scherubl H, Scheulen ME,
Germanidis G, Dominguez S, Ricci S, Nadel A, Moscovici M, Voliotis D, Llovet JM.
Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver
function: SHARP trial subanalyses.
Hepatology 2012 May;56(5):1080-8.
170. Aghemo A, Bhoori S, De Nicola S, Mazzaferro V, Colombo M.
18
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft
Reinfection.
Hepatitis Monthly 2012; 12(6):411-414.
171. Mergental H, Adam R, Ericzon BG, Kalicinski P, Mühlbacher F, Höckerstedt K,Klempnauer JL,
Friman S, Broelsch CE, Mantion G, Fernandez-Sellez C, van Hoek B, Fangmann J, Pirenne J,
Muiesan P, Königsrainer A, Mirza DF, Lerut J, Detry O, Le Treut YP, Mazzaferro V, Löhe F,
Berenguer M, Clavien PA, Rogiers X, Belghiti J, Kóbori L, Burra P, Wolf P, Schareck W, Pisarski
P, Foss A, Filipponi F, Krawczyk M, Wolff M, Langrehr JM, Rolles K, Jamieson N, Hop WC,
Porte RJ.
Liver transplantation for unresectable hepatocellular carcinoma in normal livers.
Journal of Hepatology 2012; 57(2):297-305.
172. Milione M, Pusceddu S, Gasparini P, Melotti F, Maisonneuve P, Mazzaferro V,de Braud FG,
Pelosi G.
Succinate dehydrogenase B subunit immunohistochemical expression predicts aggressiveness in
well differentiated neuroendocrine tumorsof the ileum.
Cancers (Basel). 2012 Aug 16;4(3):808-20.
Lachenmayer A, Alsinet C, Savic R, Cabellos L, Toffanin S, Hoshida Y,Villanueva A, Minguez B,
Newell P, Tsai HW, Barretina J, Thung S, Ward SC, Bruix J, Mazzaferro V, Schwartz M,
Friedman SL, Llovet JM.
Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental
modulation by sorafenib.
Clinical Cancer Research 2012, 18 (18): 4997-5007.
173. Bruix J, Raoul JL, Sherman M, Mazzaferro V, Bolondi L, Craxi A, Galle PR, Santoro A,
Beaugrand M, Sangiovanni A, Porta C, Gerken G, Marrero JA, Nadel A, Shan M, Moscovici M,
Voliotis D, Llovet JM.
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses
of a phase III trial.
Journal of Hepatology 2012;57(4):821-829.
174. Bolondi L, Burroughs A, Dufour JF, Galle PR, Mazzaferro V, Piscaglia F, Raoul JL, Sangro B.
Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a
subclassification to facilitate treatment decisions.
Semin Liver Dis. 2012;32(4):348-59.
175. Chiesa C, Mira M, Maccauro M, Romito R, Spreafico C, Sposito C, Bhoori S, Morosi C, Pellizzari
S, Negri A, Civelli E, Lanocita R, Camerini T, Bampo C, Carrara M, Seregni E, Marchianò A,
Mazzaferro V, Bombardieri E.
A dosimetric treatment planning strategy in radioembolization of hepatocarcinoma with 90Y glass
microspheres.
Q J Nucl Med Mol Imaging 2012;56(6):503-8.
176. Angelico M, Nardi A, Marianelli T, Caccamo L, Romagnoli R, Tisone G, Pinna AD, Avolio AW,
Fagiuoli S, Burra P, Strazzabosco M, Costa AN; Liver Match Investigators.
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft
survival: evidence from the Liver Match cohort study.
Journal of Hepatology 2013; 58(4):715-23.
19
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
177. Roayaie S, Obeidat K, Sposito C, Mariani L, Bhoori S, Pellegrinelli A, Labow D, Llovet JM,
Schwartz M, Mazzaferro V.
Resection of hepatocellular cancer ≤2 cm: results from two Western centers.
Hepatology. 2013 Apr;57(4):1426-35.
178. Sia D, Hoshida Y, Villanueva A, Roayaie S, Ferrer J, Tabak B, Peix J, Sole M, Tovar V, Alsinet C,
Cornella H, Klotzle B, Fan JB, Cotsoglou C, Thung SN, Fuster J, Waxman S, Garcia-Valdecasas
JC, Bruix J, Schwartz ME, Beroukhim R, Mazzaferro V, Llovet JM.
Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have
different outcomes.
Gastroenterology 2013; 144(4):829-40.
179. Mazzaferro V, Sposito C, Bhoori S, Romito R, Chiesa C, Morosi C, Maccauro M, Marchianò A,
Bongini M, Lanocita R, Civelli E, Bombardieri E, Camerini T, Spreafico C.
Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2
study.
Hepatology 2013;57(5):1826-37.
180. Buzzoni R, Pusceddu S, Damato A, Meroni E, Aktolun C, Milione M, Mazzaferro V, De Braud F,
Spreafico C, Maccauro M, Zaffaroni N, Castellani MR.
Malignant pheochromocytoma and paraganglioma: future considerations for therapy.
Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013; 57(2):153-60.
181. Damato A, Pusceddu S, Milione M, Mazzaferro V, Magli M, Seregni E, De Braud F, Buzzoni R.
Well-differentiated neuroendocrine tumor of tailgut cyst. A rare entity with controversial medical
opportunities.
Tumori 2013 Jul-Aug;99(4):e148-51.
182. Sposito C, Mariani L, Germini A, Flores Reyes M, Bongini M, Grossi G, Bhoori S, Mazzaferro V.
Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular
carcinoma after liver transplantation: a case-control study.
Journal of Hepatology 2013;59(1):59-66.
183. Roayaie S, Llovet J, Schwartz M, Mazzaferro V.
Reply.
Hepatology 2013;58(1):452-3
184. Bruzzone P, Giannarelli D, Adam R; European Liver and Intestine Transplant Association;
European Liver Transplant Registry.
A preliminary European Liver and Intestine Transplant Association-European Liver Transplant
Registry study on informed recipient consent and extended criteria liver donation.
Transpl. P. 2013 Sep;45(7):2613-5.
185. Coppa J, Citterio D, Cotsoglou C, Germini A, Piccioni F, Sposito C, Mazzaferro V.
Transhepatic anterior approach to the inferior vena cava in large retroperitoneal tumors resected en
bloc with the right liver lobe.
Surgery 2013;154(5):1061-8.
186. Bruix J, Tak WY, Gasbarrini A, Santoro A, Colombo M, Lim HY, Mazzaferro V, Wiest R, Reig
M, Wagner A, Bolondi L.
20
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma:
multicentre, open-label, phase II safety study.
Eur J Cancer. 2013;49(16):3412-3419.
187. Salem R, Mazzaferro V, Sangro B.
Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: biological lessons,
current challenges, and clinical perspectives.
Hepatology 2013;58(6):2188-97.
188. Grassi P, Verzoni E, Mariani L, De Braud F, Coppa J, Mazzaferro V, Procopio G.
Prognostic role of pancreatic metastases from renal cell carcinoma: results from an Italian center.
Clin Genitourin Cancer 2013;11(4):484-8.
189. Mazzaferro V, Roayaie S, Poon R, Majno PE.
Dissecting EASL/AASLD Recommendations With a More Careful Knife: A Comment on
"Surgical Misinterpretation" of the BCLC Staging System.
Ann Surg. 2013 Dec 23. [Epub ahead of print] No abstract available.
190. Frilling A, Modlin IM, Kidd M, Russell C, Breitenstein S, Salem R, Kwekkeboom D, Lau WY,
Klersy C, Vilgrain V, Davidson B, Siegler M, Caplin M, Solcia E, Schilsky R; Working Group on
Neuroendocrine Liver Metastases.
Recommendations for management of patients with neuroendocrine liver metastases.
Lancet Oncol. 2014 Jan;15(1):e8-21.
191. Sposito C, Mazzaferro V.
Reply to: "Time is a crucial factor for the use of oncological treatment for post-transplantation
recurrence of hepatocellular carcinoma".
Journal of Hepatology 2014;60(1):230-1.
192. Aseni P, De Feo TM, De Carlis L, Valente U, Colledan M, Cillo U, Rossi G, Mazzaferro V,
Donataccio M, De Fazio N, Andorno E, Burra P; Split-Liver Study Group.
A prospective policy development to increase split-liver transplantation for 2 adult recipients:
results of a 12-year multicenter collaborative study.
Ann Surg 2014; 259(1):157-65.
193. Seregni E, Maccauro M, Chiesa C, Mariani L, Pascali C, Mazzaferro V, De Braud F, Buzzoni R,
Milione M, Lorenzoni A, Bogni A, Coliva A, Lo Vullo S, Bombardieri E.
Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours
refractory to conventional therapy.
Eur J Nucl Med Mol Imaging 2014 Feb;41(2):223-30.
194. Sposito C, Mazzaferro V.
Reply to: "Sorafenib efficacy for treatment of HCC recurrence after liver transplantation is an open
issue”
Journal of Hepatology. 2014 Mar;60(3):682-3.
195. Lesurtel M, Nagorney DM, Mazzaferro V, Jensen RT, Poston GJ.
When should a liver resection be performed in patients with liver metastases from neuroendocrine
tumours? A systematic review with practice recommendations.
HPB (Oxford). 2014 Mar 17. doi: 10.1111/hpb.12225. [Epub ahead of print]
21
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
196. Spreafico C, Maccauro M, Mazzaferro V, Chiesa C.
The dosimetric importance of the number of 90Y microspheres in liver transarterial
radioembolization (TARE).
Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):634-8.
197. Angelico M, Nardi A, Romagnoli R, Marianelli T, Corradini SG, Tandoi F, Gavrila C, Salizzoni
M, Pinna AD, Cillo U, Gridelli B, De Carlis LG, Colledan M, Gerunda GE, Costa AN,
Strazzabosco M; Liver Match Study Investigators.
A Bayesian methodology to improve prediction of early graft loss after liver transplantation
derived from the Liver Match study.
Dig Liver Dis. 2014 Apr;46(4):340-7.
198. Bruix J, Gores GJ, Mazzaferro V.
Hepatocellular carcinoma: clinical frontiers and perspectives.
Gut. 2014 May;63(5):844-55.
199. Buzzoni R, Pusceddu S, Bajetta E, De Braud F, Platania M, Iannacone C, Cantore M, Mambrini A,
Bertolini A, Alabiso O, Ciarlo A, Turco C, Mazzaferro V.
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing
after prior chemotherapy: a phase II ITMO study.
Ann Oncol. 2014 Aug;25(8):1597-603
200. Spreafico C, Cascella T, Facciorusso A, Sposito C, Rodolfo L, Morosi C, Civelli EM, Vaiani M,
Bhoori S, Pellegrinelli A, Marchianò A, Mazzaferro V.
Transarterial Chemoembolization for Hepatocellular Carcinoma with a New Generation of Beads:
Clinical-Radiological Outcomes and Safety Profile.
Cardiovasc Intervent Radiol. 2014 May 29. [Epub ahead of print]
201. Piccioni F, Fumagalli L, Garbagnati F, Di Tolla G, Mazzaferro V, Langer M.
Thoracic paravertebral anesthesia for percutaneous radiofrequency ablation of hepatic tumors.
J Clin Anesth. 2014 Jun;26(4):271-5.
202. Milione M, Gasparini P, Sozzi G, Mazzaferro V, Ferrari A, Casali PG, Perrone F, Tamborini E,
Pellegrinelli A, Gherardi G, Arrigoni G, Collini P, Testi A, De Paoli E, Aiello A, Pilotti S, Pelosi
G.
Ewing sarcoma of the small bowel: a study of seven cases, including one with the uncommonly
reported EWSR1-FEV translocation.
Histopathology. 2014 Jun;64(7):1014-26.
203. Spreafico C, Morosi C, Maccauro M, Romito R, Lanocita R, Civelli EM, Sposito C, Bhoori S,
Chiesa C, Frigerio LF, Lorenzoni A, Cascella T, Marchianò A, Mazzaferro V.
Intrahepatic Flow Redistribution in Patients Treated with Radioembolization.
Cardiovasc Intervent Radiol. 2014 Jun 14. [Epub ahead of print]
204. Fan ST, Le Treut YP, Mazzaferro V, Burroughs AK, Olausson M, Breitenstein S, Frilling A.
Liver transplantation for neuroendocrine tumour liver metastases.
HPB (Oxford). 2014 July 3. doi: 10.1111/hpb.12308. [Epub ahead of print]
22
PUBBLICAZIONI V. MAZZAFERRO SU RIVISTE INDICIZZATE
205. Toso C, Mazzaferro V, Bruix J, Freeman R, Mentha G, Majno P.
Toward a better liver graft allocation that accounts for candidates with and without hepatocellular
carcinoma.
Am J Transplant. 2014 Oct;14(10):2221-7.
206. Bhoori S, Mazzaferro V.
Current challenges in liver transplantation for hepatocellular carcinoma.
Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):867-79. IF 3.277
207. Bruix J, Gores G, Mazzaferro V.
Authors' response to the letter: Liver resection for patients with hepatocellular carcinoma and
macrovascular invasion, multiple tumours or portal hypertension by Zhong et al.
Gut. 2014 Oct 13. pii: gutjnl-2014-308381. doi: 10.1136/gutjnl-2014-308381. [Epub ahead of
print]
208. Mazzaferro V, Lencioni R, Majno P.
Early hepatocellular carcinoma on the procrustean bed of ablation, resection, and transplantation.
Semin Liver Dis. 2014 Nov;34(4):415-26.
h-index aggiornato al 12/2014: 51 (fonte: Web of Science)
23